---
title: "Stepan Q2 FY26 adjusted EBITDA climbs 45% to USD 74.4 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294212743.md"
description: "Stepan Company reported a 45% year-over-year increase in Q2 FY26 adjusted EBITDA to USD 74.4 million, driven by organic volume growth and margin recovery. Net sales rose 18% to USD 483.9 million, while adjusted net income more than doubled to USD 14.6 million. The company also improved its net leverage ratio to 2.5x from 2.9x, with Project Catalyst on track for USD 100 million in savings."
datetime: "2026-07-29T13:04:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294212743.md)
  - [en](https://longbridge.com/en/news/294212743.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294212743.md)
generator: "portal-rs"
---

# Stepan Q2 FY26 adjusted EBITDA climbs 45% to USD 74.4 million

-   Stepan posted Q2 2026 adjusted EBITDA of USD 74.4 million, up 45% year over year, on broad-based organic volume growth and margin recovery. \* Adjusted net income more than doubled to USD 14.6 million; adjusted EPS rose to USD 1.18. \* Net sales climbed 18% to USD 483.9 million, driven by 7% organic volume growth and a 12% increase in price/mix. \* Net debt was USD 533.7 million at June 30, 2026; net leverage ratio improved to 2.5x from 2.9x a year earlier. \* Project Catalyst remained on track for about USD 100 million in pre-tax savings over two years, with a salaried workforce reduction planned by year-end. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stepan Company published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SCL.US](https://longbridge.com/en/quote/SCL.US.md)

## Related News & Research

- [Stepan (SCL) Following Its New $500 Million Credit Facility Looks Undervalued](https://longbridge.com/en/news/301177430.md)
- [Here's Why We're Wary Of Buying Stepan's (NYSE:SCL) For Its Upcoming Dividend](https://longbridge.com/en/news/297325933.md)
- [Micron Stock Price Forecast: Unlikely to Break Record High of $1,255 in Short Term Amid Taiwan Strike Risk](https://longbridge.com/en/news/301253443.md)
- [Viatris agrees to buy Pacira BioSciences for $36.50 a share in cash, valuing deal at $1.65 billion](https://longbridge.com/en/news/301270461.md)
- [Is Nvidia, at Bargain Levels Right Now, a Buy? Here Are the Bull and Bear Cases.](https://longbridge.com/en/news/301252495.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**